Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Enterprise Value (2016 - 2025)

Conmed's Enterprise Value history spans 16 years, with the latest figure at -$40.8 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 66.88% year-over-year to -$40.8 million; the TTM value through Dec 2025 reached -$40.8 million, down 66.88%, while the annual FY2025 figure was -$40.8 million, 66.88% down from the prior year.
  • Enterprise Value reached -$40.8 million in Q4 2025 per CNMD's latest filing, down from -$38.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$20.8 million in Q4 2021 to a low of -$53.2 million in Q2 2022.
  • Average Enterprise Value over 5 years is -$33.0 million, with a median of -$32.4 million recorded in 2021.
  • Peak YoY movement for Enterprise Value: skyrocketed 47.61% in 2023, then plummeted 66.88% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$20.8 million in 2021, then tumbled by 38.83% to -$28.9 million in 2022, then rose by 16.05% to -$24.3 million in 2023, then dropped by 0.67% to -$24.5 million in 2024, then tumbled by 66.88% to -$40.8 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Enterprise Value are -$40.8 million (Q4 2025), -$38.9 million (Q3 2025), and -$33.9 million (Q2 2025).